Tesla (NASDAQ:TSLA) will be under the Street’s microscope today with the EV giant slated to release 4Q24 results after the ...

Fintel reports that on January 29, 2025, Goldman Sachs downgraded their outlook for Moderna (NasdaqGS:MRNA) from Buy to ...

Moderna Inc (NASDAQ:MRNA) shares are trading lower Wednesday after Goldman Sachs downgraded the stock. Here's what you need ...

Wall Street is mainly focused on Apple's iPhone sales in China and any guidance related to its March quarter, which could ...

Shares of vaccine maker Moderna Inc. fell Wednesday as Goldman Sachs lowered its rating after the biotech's second cut to product revenue guidance in six months. Moderna shares (MRNA) fell 2% in ...

Goldman Sachs's “Rule of 10” aims to identify the next wave of S&P 500 stocks capable of delivering the most capital appreciation by focusing on past and future revenues. It's a stock screen, which ...

Peter Oppenheimer, the chief of global equity strategy and the head of macro research for Goldman Sachs in Europe, opined that the rise of tech stocks due to the AI boom was not ...

The Bank of England is likely to cut interest rates far further and faster than markets are currently expecting, according to ...

The meteoric rise of Chinese start-up DeepSeek may have shaken Wall Street's confidence in some favorite trades, but it’s unlikely to change the immediate outlook for the spending that has fueled the ...

Moderna (NASDAQ:MRNA) shares about 3% ahead of Wednesday market open after Goldman Sachs cut its rating on the stock to Neutral from Buy.

The Chinese startup's new model poses some serious questions about the assumptions behind AI investments. But what if that's ...

Goldman Sachs has hired Daniel Marcu from Amazon.com as its global head of artificial intelligence engineering and science to help develop and refine artificial intelligence platforms and products, ...